Pelthos Therapeutics
$26.01
0
-$1.23-4.52% Today
Statistics
Day High
29.64
Day Low
26.01
52W High
135
52W Low
16.18
Volume
2,825,330
Avg. Volume
-
Mkt Cap
79.64M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
14MayExpected
Expected EPS
-3.45
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-15.91MNet Income
Analyst Ratings
55Average Price Target
The highest estimate is 62.00.
From 5 ratings within the last 6 months. This is not an investment recommendation.
From 5 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PTHS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company offers ZELSUVMI for the treatment of molluscum contagiosum in adults and children 1 year of age and older. It also provides NITRICIL, a proprietary nitric oxide-based technology platform. The company was formerly known as Channel Therapeutics Corporation and changed its name to Pelthos Therapeutics Inc. in July 2025. Pelthos Therapeutics Inc. was founded in 2002 and is based in Durham, North Carolina.
Show more...
CEO
Mr. Scott M. Plesha
Employees
4
Country
United States
ISIN
US1711262048
Listings
0 Comments
Share your thoughts
FAQ
What is Pelthos Therapeutics stock price today?▼
The current price of PTHS is $26.01 USD — it has decreased by -4.52% in the past 24 hours. Watch Pelthos Therapeutics stock price performance more closely on the chart.
What is Pelthos Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Pelthos Therapeutics stocks are traded under the ticker PTHS.
Is Pelthos Therapeutics stock price growing?▼
PTHS stock has risen by +3.6% compared to the previous week, the month change is a +13.09% rise, over the last year Pelthos Therapeutics has showed a -75.69% decrease.
What is Pelthos Therapeutics market cap?▼
Today Pelthos Therapeutics has the market capitalization of 79.64M
When is the next Pelthos Therapeutics earnings date?▼
Pelthos Therapeutics is going to release the next earnings report on May 14, 2026.
What were Pelthos Therapeutics earnings last quarter?▼
PTHS earnings for the last quarter are -6.87 USD per share, whereas the estimation was -3.7 USD resulting in a -85.84% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pelthos Therapeutics revenue for the last year?▼
Pelthos Therapeutics revenue for the last year amounts to 0 USD.
What is Pelthos Therapeutics net income for the last year?▼
PTHS net income for the last year is -15.91M USD.
How many employees does Pelthos Therapeutics have?▼
As of May 13, 2026, the company has 4 employees.
In which sector is Pelthos Therapeutics located?▼
Pelthos Therapeutics operates in the Health & Wellness sector.
When did Pelthos Therapeutics complete a stock split?▼
The last stock split for Pelthos Therapeutics was on July 02, 2025 with a ratio of 1:10.
Where is Pelthos Therapeutics headquartered?▼
Pelthos Therapeutics is headquartered in Durham, United States.